Literature DB >> 3626926

Campylobacter jejuni/Campylobacter coli-associated Guillain-Barré syndrome. Immunoblot confirmation of the serological response.

B R Speed, J Kaldor, J Watson, H Newton-John, W Tee, D Noonan, B W Dwyer.   

Abstract

Immunoblot (Western blot) examination of the sera of 45 patients with the Guillain-Barré syndrome demonstrated that between three and five immunoreactive bands that were characteristic of a recent Campylobacter jejuni/Campylobacter coli infection were present in 22 of these patients. The immunoblots paralleled the serological response that is found in campylobacter enteritis and confirmed the specificity of our previous enzyme-linked immunosorbent assays (ELISAs), which indicates that antecedent C. jejuni/C. coli infection is common in patients with the Guillain-Barré syndrome. We postulate that, under certain circumstances, demyelination is initiated by the leakage of campylobacter-specific antibody across the blood-nerve barrier.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3626926     DOI: 10.5694/j.1326-5377.1987.tb133228.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.

Authors:  Ruprecht Schmidt-Ott; Holger Schmidt; Sylvia Feldmann; Felicitas Brass; Bernd Krone; Uwe Gross
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Campylobacter Enteritis and the Guillain-Barré Syndrome.

Authors:  Irving Nachamkin
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 3.  Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review.

Authors:  Kate O Poropatich; Christa L Fischer Walker; Robert E Black
Journal:  J Health Popul Nutr       Date:  2010-12       Impact factor: 2.000

4.  Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations.

Authors:  I B Autenrieth; A Schwarzkopf; J H Ewald; H Karch; R Lissner
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 5.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.